Correlation Engine 2.0
Clear Search sequence regions


  • allograft (6)
  • atp (1)
  • caspases (1)
  • cytokines (1)
  • graft (2)
  • humans (1)
  • IL 1 (4)
  • IL 1β (3)
  • inflammasomes (5)
  • ischemia (1)
  • molecular weight (1)
  • neutrophil (1)
  • NLRP3 (1)
  • pathogen (3)
  • pathogenesis (1)
  • pyroptosis (1)
  • receptor (1)
  • signal (4)
  • t cell (1)
  • TLRs (1)
  • uric acid (1)
  • Sizes of these terms reflect their relevance to your search.

    Inflammasomes are high-molecular-weight cytosolic complexes that mediate the activation of caspases. There are many inflammasomes, and each is influenced by a unique pattern-recognition receptor response. Two signals are typically involved in the inflammasome pathways. Signal one involves recognition of pathogen-associated molecular patterns (PAMPs), such as LPS or other colonizing/invading microbes, that interact with TLRs, which induce the downstream production of pro-IL-1β. This is followed by signal two, which involves recognition of PAMPs or damage-associated molecular patterns (DAMPs), such as uric acid or ATP, via NLRP3, which leads to caspase-1-dependent cleavage of pro-IL-1β to active IL-1β and pyroptosis. Ultimately, these two signals cause the release of multiple proinflammatory cytokines. Both PAMPs and DAMPs can be liberated by early insults to the allograft, including ischemia/reperfusion injury, infections, and rejection. The consequence of inflammasome activation and IL-1 expression is the upregulation of adhesion molecules and chemokines, which leads to allograft neutrophil sequestration, mononuclear phagocyte recruitment, and T cell activation, all of which are key steps in the continuum from allograft insult to chronic allograft dysfunction.

    Citation

    S Samuel Weigt, Vyacheslav Palchevskiy, John A Belperio. Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction. The Journal of clinical investigation. 2017 Jun 01;127(6):2022-2029

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28569730

    View Full Text